Bone Metastases (update of QLQ-BM22)

Gender Neutral
Type Module
Testing Phase I - in development
Principal investigator(s)
Edward Chow
Odette Cancer Centre
Toronto, Canada

Project summary

This project aims:

  1. To update the current EORTC QLQ-BM22 to encompass QoL issues relevant to recent therapeutic interventions.
  2. To identify any problematic items and/scales in the BM22.
  3. To enhance cultural relevance of the BM22 through collaboration with countries not included in the original module development.

Achievements

Main contract signed
Recruit the collaborators now

Future plans

The phase 1 update will start in the next 12 months

For patients

The existing BM22 module requires an update to account for the changing landscape in clinical practice. Indeed, it has been over 11 years since the development of our module, and according to the EORTC QLG Module Development Guidelines, it is recommended that existing modules be reviewed and considered for an update if treatments have evolved during the last decade. We believe this is the case and that an updated module would be of clinical interest for this common disease entity.

Go to Top